期刊文献+

重组人生长激素治疗不同生长激素分泌状态青春前期矮小患儿追赶性生长模式分析 被引量:13

Analysis of catch-up growth pattern to recombinant human growth hormone treatment in prepubertal children with short stature and various secretory forms of growth hormone
原文传递
导出
摘要 目的比较不同生长激素(GH)分泌状态矮小患儿重组人生长激素(rhGH)治疗后的初始追赶性生长模式,初步探讨其机制。方法回顾性分析62例青春前期不同GH分泌状态矮小患儿对rhGH治疗1年半的追赶性生长模式并定期监测体格指标、促生长素轴的血清指标和骨龄。结果各组在初始追赶性生长的幅度相似,特发性矮小(ISS)组比完全性生长激素缺乏症(GHD)组更早出现生长减速,并与生长激素结合蛋白(GHBP)水平降低和胰岛素样生长因子结合蛋白3的标准差分数(SDS)增值较小显著相关。GH激发峰值(GHmax)〉7μg/L的部分性GHD组与ISS组有类同的生长追赶的模式。结论GH受体的降调节和受体后效应的降低可能是ISS组较早出现生长减速的机制。以GHmax7μg/L作为GHD诊断的界值并相应选择rhGH治疗剂量有更充分的依据和临床意义。 Objective To analyze the pattern of early catch-up growth in children with prepubertal short stature and various secretory forms of growth hormone(GH) following recombinant human growth hormone(rhGH) treatment and to explore the mechanism. Methods Sixty-two children with prepubertal short stature and various GH secretory forms were analyzed retrospectively, 27 with complete growth hormone deficiency (cGHD) , 23 with partial growth hormone deficiency (pGHD) and 12 with idiopathic short stature (ISS). According to the GH peak value in GH provocative test, the group of pGHD was divided into pGHD-1 (5.0-6.9 μg/L) and pGHD-2 (7.0- 9.9 μg/L). Height velocity, increase in height standard differentiation score (SDS) , was calculated; serum levels of somatotrophic axis hormone were detected and bone age was determined. Results The quick early catch-up growth in different groups were similar in the initial 6 months. While that in the ISS group persisted for shorter period and was correlated with lower level in serum GH-binding protein ( r = 0. 526, P = 0. 025 ) and △insulin-like growth factor-binding protein-3 ( IGFBP-3 ) SDS( r = 0. 532 ,P = 0. 034 ) after rhGH treatment. The same doses of rhGH were applied to children with cGHD and pGHD. Children with pGHD-1 showed similar response to rhGH, regarding height velocity and △IGFBP-3 SDS, as compared with those of cGHD. However, children with pGHD-2 presented similar response with ISS, being worse than cGHD. Conclusion Downregulation of GH receptor and decrease in post-receptor effect seem to be the mechanism leading to early retardation in ISS. The incomplete catch- up growth in pGHD-2 may be caused by relatively inadequate rhGH dose. The cut-off value of GH provocative test in diagnosing GHD is more reasonable to be 7 μg/L.
出处 《中华内分泌代谢杂志》 CAS CSCD 北大核心 2008年第3期239-243,共5页 Chinese Journal of Endocrinology and Metabolism
关键词 生长激素 生长激素缺乏症 特发性矮小 追赶生长 Growth hormone Growth hormone deficiency Idiopathic short stature Catch-up growth
  • 相关文献

参考文献22

  • 1Edward OR, David AP, Patrick W, et al. Effect of growth hormone (GH) treatment on the near-final height of 1258 patients with idiopathic GH deficiency: analysis of a large international database. J Clin Endocrinol Metab, 2006,91:2047-2054.
  • 2Ellen WL, Susan RR, Jack AY, et al. Effect of growth hormone treatment on adult height in peripubertal children with idiopathic short stature: A randomized, double-blind, placebo-controlled trial. J Clin Endocrinol Metab, 2004,89:3140-3148.
  • 3李燕虹,杜敏联,马华梅,何俏华,赖峰,古玉芬.吡啶斯的明与左旋多巴联合激发试验对儿童生长激素缺乏症的诊断价值[J].中华内分泌代谢杂志,2004,20(3):227-230. 被引量:36
  • 4Greulich WW, Pyle SI. Radiographic atlas of skeletal development of hand and wrist, 2nd ed. Califonia: Stanford University Press, 1959.
  • 5胡亚美 江载芳.诸福棠实用儿科学(7版)[M].北京:人民卫生出版社,2002.877.
  • 6Merimee TJ, Russell B, Quinn S. Growth hormone-binding protein of human serum: development patterns in normal man. J Clin Endocrinol Metab, 1992,75:852-854.
  • 7Harvey JG. Four decades of growth hormone therapy for short children : what have we achieved? J Clin Endocrinol Metab, 1999,84:4307- 4316.
  • 8Ranke MB, Schwarze CP, Mohnike CK, et al. Catch-up growth after childhood-onset substitution in primary hypothyroidism: is it a guide towards optimal growth hormone treatment in idiopathic growth hormone deficiency? Horm Res,1998,50:264-270.
  • 9Prader A, Tanner JM, von Harnack G. Catch-up growth following illness or starvation. An example of developmental canalization in man, J Pediatr,1963 ,62 :646-659.
  • 10潘思年,杜敏联,陈红珊,李燕虹,马华梅,黄婷婷.重组人生长激素治疗生长激素缺乏症患儿影响生长速度疗效的因素[J].中华儿科杂志,2006,44(7):544-545. 被引量:4

二级参考文献28

  • 1李燕虹,杜敏联,马华梅,何俏华,赖峰,古玉芬.吡啶斯的明与左旋多巴联合激发试验对儿童生长激素缺乏症的诊断价值[J].中华内分泌代谢杂志,2004,20(3):227-230. 被引量:36
  • 2李堂,杜嗣廉,林荣军.吡啶斯的明对生长激素缺乏症儿生长激素分泌的激发作用[J].实用儿科临床杂志,1996,11(2):83-84. 被引量:4
  • 3Rosenfeld NG, Albertsson-Wikland K, Cassorla F, et al. Diagnostic controversy: the diagnosis of childhood growth hormone deficiency revisited. J Clin Endocrinol Metab, 1995,80:1532-1540.
  • 4Tanner JM, Davies PSW. Clinical longitudinal standards for height and height velocity for North American children. J Pediatr, 1985,107:317-329.
  • 5Ghigo E, Bellone J, Aimaretti G, et al. Reliability of provocative tests to assess growth hormone secretory status. Study in 472 normally growing children. J Clin Endocrinol Metab, 1996,81:3323-3327.
  • 6Friend K, Iranmanesh A, Login IS, et al. Pyridostigmine treatment selectively amplifies the mass of GH secreted per burst without altering GH burst frequency, half-life, basal GH secretion or the orderliness of GH release. Eur Endocrinol J, 1997,137:377-3
  • 7Shah A, Stanhope R, Matthews D. Harzards of pharmacological tests of growth hormone secretion in childhood. Br Med J, 1992,304:173-174.
  • 8Carel CJ, Tresca JP, Letrait M, et al. Growth hormone testing for the diagnosis of growth hormone deficiency in childhood: a population register-based study. J Clin Endocrinol Metab, 1997,82:2117-2121.
  • 9Tillmann V, Buckler JMH, Kibirige MS, et al. Biochemical tests in the diagnosis of childhood growth hormone deficiency. J Clin Endocrinol Metab, 1997,82:531-535.
  • 10Rosenfeld RG, Albertsson-Wikland K, Cassorla F, et al. Diagnostic controversy: the diagnosis of childhood growth hormone deficiency revisited. J Clin Endocrinol Metab, 1995,80:1532-1540.

共引文献69

同被引文献127

引证文献13

二级引证文献52

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部